Delayed treatment with 5-nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione, a glycine site N-methyl-D-aspartate antagonist, protects against permanent middle cerebral artery occlusion in male rats.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neuroscience Letters

• Publication date

  2003-08-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0304-3940(03)00693-1PMID 12875907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects

  2002cited by this paper
• Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and non-diabetic Fischer 344 rats.

  2002cited by this paper
• Glutamate release and neuronal damage in ischemia.

  2001cited by this paper
• Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.

  2001cited by this paper
• Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats.

  1999cited by this paper
• Mg2+-dependent modification of the N-methyl-D-aspartate receptor following graded hypoxia in the cerebral cortex of newborn piglets.

  1999cited by this paper
• Neuroprotective Effect of NMDA Receptor Glycine Recognition Site Antagonism Persists When Brain Temperature is Controlled

  1997cited by this paper
• Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

  1996cited by this paper
• In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.

  1995cited by this paper
• Cytoprotective therapies in stroke.

  1995cited by this paper
• In vivo Models of Cerebral Ischemia: Effects of Parenterally Administered NMDA Receptor Glycine Site Antagonists

  1995cited by this paper
• The Effect of the Glycine Site-Specific N-Methyl-d-Aspartate Antagonist ACEA1021 on Ischemic Brain Damage Caused by Acute Subdural Hematoma in the Rat

  1995cited by this paper
• The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model.

  1992cited by this paper
• The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischemia model

  1992cited by this paper
• Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition.

  1991cited by this paper
• A Semiautomated Method for Measuring Brain Infarct Volume

  1990cited by this paper
• Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?

  1990cited by this paper
• Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.

  1988cited by this paper
• The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat

  1988cited by this paper
• Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

  1984cited by this paper
• Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

  1981cited by this paper

• Therapeutic time windows of compounds against NMDA receptors signaling pathways for ischemic stroke

  2021cites this paper
• Treatment of acute cerebral ischemia using animal models: a meta-analysis

  2015cites this paper
• Trea Tmen T of acu Te cerebral ischemia using animal models

  2015cites this paper
• Efficient synthesis of diethyltetrahydroquinoxalinediones

  2015cites this paper
• An unexpected oxidative decarboxylation reaction of 2,3-dihydroxybenzoic acid in the synthesis of new dibenzyltetrahydroquinoxalinediones

  2014cites this paper
• Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds.

  2006cites this paper
• ACEA 1021: flip or flop?

  2006cites this paper
• A facile galvanostatic method for the synthesis of quinoxalinediones

  2006cites this paper
• 17β-Estradiol treatment following permanent focal ischemia does not influence recovery of sensorimotor function

  2006cites this paper
• Chemistry, biological properties and SAR analysis of quinoxalinones.

  2006cites this paper
• Post-exposure treatment attenuates noise-induced hearing loss.

  2005cites this paper
• Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias

  2004cites this paper